Tenax Therapeutics Inc (TENX)
3.14
-0.06
(-1.88%)
USD |
NASDAQ |
Jun 14, 16:00
3.18
+0.04
(+1.27%)
After-Hours: 20:00
Tenax Therapeutics Shareholders Equity (Quarterly): 12.43M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.43M |
December 31, 2023 | 8.098M |
September 30, 2023 | 11.29M |
June 30, 2023 | 13.22M |
March 31, 2023 | 14.28M |
December 31, 2022 | 1.493M |
September 30, 2022 | 3.954M |
June 30, 2022 | 6.784M |
March 31, 2022 | 1.606M |
December 31, 2021 | 4.245M |
September 30, 2021 | 7.239M |
June 30, 2021 | 1.471M |
March 31, 2021 | 3.096M |
December 31, 2020 | 4.626M |
September 30, 2020 | 7.404M |
June 30, 2020 | 3.029M |
March 31, 2020 | 3.419M |
December 31, 2019 | 3.772M |
September 30, 2019 | 6.536M |
June 30, 2019 | 8.620M |
March 31, 2019 | 10.34M |
December 31, 2018 | 11.77M |
September 30, 2018 | 4.938M |
June 30, 2018 | 6.233M |
March 31, 2018 | 8.001M |
Date | Value |
---|---|
December 31, 2017 | 8.882M |
September 30, 2017 | 10.16M |
June 30, 2017 | 11.27M |
March 31, 2017 | 14.11M |
December 31, 2016 | 17.14M |
September 30, 2016 | 46.69M |
June 30, 2016 | 50.89M |
March 31, 2016 | 55.33M |
October 31, 2015 | 63.93M |
July 31, 2015 | 67.37M |
April 30, 2015 | 70.43M |
January 31, 2015 | 75.36M |
October 31, 2014 | 77.59M |
July 31, 2014 | 81.54M |
April 30, 2014 | 82.89M |
January 31, 2014 | 30.30M |
October 31, 2013 | 2.853M |
July 31, 2013 | 1.130M |
April 30, 2013 | -1.778M |
January 31, 2013 | -1.601M |
October 31, 2012 | -0.058M |
July 31, 2012 | -0.6383M |
April 30, 2012 | -0.346M |
January 31, 2012 | -0.8715M |
October 31, 2011 | -3.726M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.471M
Minimum
Jun 2021
14.28M
Maximum
Mar 2023
6.330M
Average
5.581M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.46M |
Total Liabilities (Quarterly) | 2.031M |